Medicare’s Landmark Drug Price Negotiation: What It Means for You 💊💸

The Biden administration has unveiled the next 15 prescription drugs subject to Medicare price negotiations under the Inflation Reduction Act. This historic move aims to lower healthcare costs for millions of seniors, but what does it mean for the pharmaceutical industry, Medicare beneficiaries, and the future of innovation in medicine?

In this video, we’ll explore:

The list of medications under negotiation.
The financial and personal impacts for seniors.
The controversy surrounding the negotiations and what the incoming Trump administration might change.
🔔 Subscribe to Wealthy Business for updates on finance, healthcare, and personal growth.